-
1
-
-
0036741488
-
Statins and renal function
-
Elisaf M, Mikhailidis DP. Statins and renal function. Angiology. 2002; 53: 493-502.
-
(2002)
Angiology
, vol.53
, pp. 493-502
-
-
Elisaf, M.1
Mikhailidis, D.P.2
-
2
-
-
0034649302
-
Mental stress induces transient endothelial dysfunction in humans
-
Ghiadoni L, Donald A, Cropley M, et al. Mental stress induces transient endothelial dysfunction in humans. Circulation. 2000; 14: 2473-2478.
-
(2000)
Circulation
, vol.14
, pp. 2473-2478
-
-
Ghiadoni, L.1
Donald, A.2
Cropley, M.3
-
3
-
-
0034791021
-
Endothelial dysfunction and inflamation - is there a link?
-
Stenvinkel P. Endothelial dysfunction and inflamation - is there a link? Nephrol Dial Transplant. 2001; 16: 1968-71.
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 1968-1971
-
-
Stenvinkel, P.1
-
4
-
-
0033755958
-
Endothelial cell activation injury, damage and dysfunction: Separate entities or mutual terms?
-
Blann AD. Endothelial cell activation injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul Fibrinolysis. 2000; 7: 623-630.
-
(2000)
Blood Coagul Fibrinolysis
, vol.7
, pp. 623-630
-
-
Blann, A.D.1
-
5
-
-
0037406338
-
Endothelial dysfunction and inflammation: What is the link?
-
Galle J, Quasching T, Seibold S, et al. Endothelial dysfunction and inflammation: what is the link? Kidney Int. 2003; 63 (Suppl 84): S45-S49.
-
(2003)
Kidney Int
, vol.63
, Issue.SUPPL. 84
-
-
Galle, J.1
Quasching, T.2
Seibold, S.3
-
6
-
-
0036362469
-
Fibrinolysis in chronic renal failure, dialysis and renal transplantation
-
Opatmy K, Zemanova P, Opartna S, et al. Fibrinolysis in chronic renal failure, dialysis and renal transplantation. Ann Transplant. 2002; 7: 34-35.
-
(2002)
Ann Transplant
, vol.7
, pp. 34-35
-
-
Opatmy, K.1
Zemanova, P.2
Opartna, S.3
-
7
-
-
0032127738
-
Regulation of local tissue type plasminogen activator release by endothelium independent agonists in human vasculatione
-
Stein CM. Regulation of local tissue type plasminogen activator release by endothelium independent agonists in human vasculatione. J Am Coll Cardiol. 1998; 32: 117-122.
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 117-122
-
-
Stein, C.M.1
-
8
-
-
0034808298
-
Clinically important factors influencing endothelial function
-
Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit. 2001; 7: 1075-1085.
-
(2001)
Med Sci Monit
, vol.7
, pp. 1075-1085
-
-
Vapaatalo, H.1
Mervaala, E.2
-
9
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification
-
National Kidney Foundation
-
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am Kidney Dis. 2002; 39: S1-S266.
-
(2002)
Am Kidney Dis
, vol.39
-
-
-
10
-
-
0242441465
-
-
Kidney disease as a risk factor for development of cardiovascular disease a Statement From the American Heart Association Councils of Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003; 42: 1050-1065
-
Kidney disease as a risk factor for development of cardiovascular disease a Statement From the American Heart Association Councils of Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003; 42: 1050-1065.
-
-
-
-
11
-
-
16644393405
-
Cardiovascular risk in chronic kidney disease
-
Anavekar NS, Pfeffer MA. Cardiovascular risk in chronic kidney disease. Kidney Int. 2004; S92: 11-15.
-
(2004)
Kidney Int
, vol.S92
, pp. 11-15
-
-
Anavekar, N.S.1
Pfeffer, M.A.2
-
12
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1308.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1308
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
-
13
-
-
0035997866
-
Cardiorenal risk: An important clinical intersection
-
McCullough PA. Cardiorenal risk: an important clinical intersection. Rev In Cardiovasc Med. 2002; 2: 71-76.
-
(2002)
Rev In Cardiovasc Med
, vol.2
, pp. 71-76
-
-
McCullough, P.A.1
-
14
-
-
0036406195
-
Risk factors for late kidney allograft failure
-
Ponticelli C, Villa M, Cesana B, et al. Risk factors for late kidney allograft failure. Kidney Int. 2002; 62: 1848-1854.
-
(2002)
Kidney Int
, vol.62
, pp. 1848-1854
-
-
Ponticelli, C.1
Villa, M.2
Cesana, B.3
-
15
-
-
34848843855
-
Transplantologia kliniczna
-
Rowiński W, Wałaszewski J, Pa̧czek L, eds
-
Rowiński W, Wałaszewski J, Pa̧czek L, eds. Transplantologia kliniczna. Warszawa, WL PZWL, 2004.
-
(2004)
Warszawa, WL PZWL
-
-
-
16
-
-
0032244657
-
The effect of cyclosporine on regulators of fibrinolysis in plasma allograft recipients
-
Elhasade AS, Perkowska A, Pa̧czek L, et al. The effect of cyclosporine on regulators of fibrinolysis in plasma allograft recipients. Ann Transplant. 1998; 3: 13-18.
-
(1998)
Ann Transplant
, vol.3
, pp. 13-18
-
-
Elhasade, A.S.1
Perkowska, A.2
Pa̧czek, L.3
-
17
-
-
0029769508
-
The coagulolytic system and endothelial function in cyclosporine kidney allograft recipients
-
Małyszko J, Małyszko JS, Pawlak K, et al. The coagulolytic system and endothelial function in cyclosporine kidney allograft recipients. Transplantation. 1996; 62: 828-830.
-
(1996)
Transplantation
, vol.62
, pp. 828-830
-
-
Małyszko, J.1
Małyszko, J.S.2
Pawlak, K.3
-
18
-
-
0036264147
-
Regulation of fibrinolysis in plasma of kidney transplant recipients
-
Perkowska A, Elhasade A, Gaciong Z, et al. Regulation of fibrinolysis in plasma of kidney transplant recipients. Transplant Proc. 2002; 34: 585-588.
-
(2002)
Transplant Proc
, vol.34
, pp. 585-588
-
-
Perkowska, A.1
Elhasade, A.2
Gaciong, Z.3
-
19
-
-
0035077680
-
An association between fibrinolytic activity and graft function in transplantation recipients
-
Perkowska A, Elhasade AS, Gaciong Z, et al. An association between fibrinolytic activity and graft function in transplantation recipients. Transplant Proc. 2001; 33: 409-411.
-
(2001)
Transplant Proc
, vol.33
, pp. 409-411
-
-
Perkowska, A.1
Elhasade, A.S.2
Gaciong, Z.3
-
20
-
-
0027371513
-
Willebrand factor and the endothelium in vascular disease
-
Blann AD. Von Willebrand factor and the endothelium in vascular disease. Br J Biochem Sci. 1993; 50: 125-134.
-
(1993)
Br J Biochem Sci
, vol.50
, pp. 125-134
-
-
Von, B.A.D.1
-
21
-
-
0030621567
-
Tkankowy aktywator plazminogenu tPA Ag i inhibitor aktywatora plazminogenu PAI-1 w czasie hemodializy u chorych z przewlekła̧ niewydolnościa̧ nerek
-
Pia̧tkowska M, Kotschy M, Nartowicz E, et al. Tkankowy aktywator plazminogenu tPA Ag i inhibitor aktywatora plazminogenu PAI-1 w czasie hemodializy u chorych z przewlekła̧ niewydolnościa̧ nerek. Pol Merk Lek. 1997; 2: 205-207.
-
(1997)
Pol Merk Lek
, vol.2
, pp. 205-207
-
-
Pia̧tkowska, M.1
Kotschy, M.2
Nartowicz, E.3
-
22
-
-
3943110721
-
Układ fibrynolizy krwi chorych na przewlekła̧ niewydolność nerek poddawanych hemodializie
-
Rość D, Bronisz M, Zastawna E, et al. Układ fibrynolizy krwi chorych na przewlekła̧ niewydolność nerek poddawanych hemodializie. Nefrol Dial Pol. 2000; 4: 156-160.
-
(2000)
Nefrol Dial Pol
, vol.4
, pp. 156-160
-
-
Rość, D.1
Bronisz, M.2
Zastawna, E.3
-
23
-
-
0029021840
-
Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment
-
Patrasi GM, Santori MT, Rigotti P, et al. Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment. Transplantation. 1995; 59: 1416-1420.
-
(1995)
Transplantation
, vol.59
, pp. 1416-1420
-
-
Patrasi, G.M.1
Santori, M.T.2
Rigotti, P.3
-
24
-
-
0345593810
-
Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients
-
van den Dorpel MA, Veld AJ, Levi M, et al. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients. Arterioscler Thromb Vasc Biol. 1999; 19: 1555-1558.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 1555-1558
-
-
van den Dorpel, M.A.1
Veld, A.J.2
Levi, M.3
-
25
-
-
0035960331
-
Vascular endothelial function in cyclosporine and tacrolimus treatment transplant recipients
-
Ovuworie CA, Fox ER, Chow P, et al. Vascular endothelial function in cyclosporine and tacrolimus treatment transplant recipients. Transplantation. 2001; 72: 1385-1388.
-
(2001)
Transplantation
, vol.72
, pp. 1385-1388
-
-
Ovuworie, C.A.1
Fox, E.R.2
Chow, P.3
-
26
-
-
0035143389
-
Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus
-
Ligtenberg G, Hene RJ, Blankestijn PJ, et al. Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol. 2001; 12: 368-373.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 368-373
-
-
Ligtenberg, G.1
Hene, R.J.2
Blankestijn, P.J.3
-
27
-
-
0027232337
-
Expression and localization of plasminogen activator inhibitor 1 mRNA in transplant kidneys
-
Wang Y, Thompson EM, Whawell SA, et al. Expression and localization of plasminogen activator inhibitor 1 mRNA in transplant kidneys. J Pathology. 1993; 169: 445-450.
-
(1993)
J Pathology
, vol.169
, pp. 445-450
-
-
Wang, Y.1
Thompson, E.M.2
Whawell, S.A.3
-
28
-
-
0028034116
-
Natural anticoagulant and fibrinolytic pathways in renal allograft failure
-
Torry RJ, Labamerre CA, Gargirlo P, et al. Natural anticoagulant and fibrinolytic pathways in renal allograft failure. Transplantation. 1994; 58: 926-931.
-
(1994)
Transplantation
, vol.58
, pp. 926-931
-
-
Torry, R.J.1
Labamerre, C.A.2
Gargirlo, P.3
-
29
-
-
0029122148
-
Von Willebrand factor, a possible indicator of endothelial damage, decreases during long-term compliance with a lipid-lowering diet
-
Blann AD, Jackson P, Bath PMW, et al. Von Willebrand factor, a possible indicator of endothelial damage, decreases during long-term compliance with a lipid-lowering diet. J Intern Med. 1995; 237: 557-561.
-
(1995)
J Intern Med
, vol.237
, pp. 557-561
-
-
Blann, A.D.1
Jackson, P.2
Bath, P.M.W.3
-
30
-
-
0026333959
-
Role of oxidized low density lipoprotein in atherogenesis
-
Witztum RJ, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991; 88: 1785-1792.
-
(1991)
J Clin Invest
, vol.88
, pp. 1785-1792
-
-
Witztum, R.J.1
Steinberg, D.2
-
31
-
-
0027250120
-
Markers of endothelial perturbation and damage
-
Pearson JD. Markers of endothelial perturbation and damage. Br J Rheumatol. 1993; 32: 651-652.
-
(1993)
Br J Rheumatol
, vol.32
, pp. 651-652
-
-
Pearson, J.D.1
-
32
-
-
0027948481
-
Vessel wall interactions regulating thrombosis
-
Pearson JD. Vessel wall interactions regulating thrombosis. Br Med Bull. 1994; 50: 776-788.
-
(1994)
Br Med Bull
, vol.50
, pp. 776-788
-
-
Pearson, J.D.1
|